Publication | Closed Access

A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis

EpidemiologyModerate-to-severe Ulcerative ColitisGastroenterologyOutcomes ResearchReal Life ComparisonClinical GastroenterologyUlcerative ColitisPropensity Score AnalysisMedicineRheumatoid Arthritis